Hydronephrosis natural history, complications and prognosis
Hydronephrosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hydronephrosis natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Hydronephrosis natural history, complications and prognosis |
FDA on Hydronephrosis natural history, complications and prognosis |
CDC on Hydronephrosis natural history, complications and prognosis |
Hydronephrosis natural history, complications and prognosis in the news |
Blogs on Hydronephrosis natural history, complications and prognosis |
Risk calculators and risk factors for Hydronephrosis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
Common complications of hydronephrosis include infections, hyperkalemia, metabolic acidosis, and distal renal tubular acidosis, hypertension and renal failure.
Prognosis is generally excellent, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of hydronephrosis can usually develop at any age depending on the underlying cause and present with symptoms such as, flank pain/abdominal pain, nausea, vomiting, burning and painful micturition, incomplete voiding.
Complications
- Common complications of hydronephrosis include:[1][2][3][4][5]
- Infection secondary to obstruction
- Electrolyte imbalance
- Hyperkalemia
- Metabolic acidosis
- Distal renal tubular acidosis
- Excessive freewater diuresis
- Hypertension
- Real insufficiency and renal failure
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
- Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
References
- ↑ Kozeny GA, Hurley RM, Vertuno LL, Bansal VK, Zeller WP, Hano JE (1986). "Hypertension, mineralocorticoid-resistant hyperkalemia, and hyperchloremic acidosis in an infant with obstructive uropathy". Am. J. Nephrol. 6 (6): 476–81. doi:10.1159/000167258. PMID 3565506.
- ↑ Chandar J, Abitbol C, Zilleruelo G, Gosalbez R, Montané B, Strauss J (February 1996). "Renal tubular abnormalities in infants with hydronephrosis". J. Urol. 155 (2): 660–3. PMID 8558697.
- ↑ Lee JH, Choi HS, Kim JK, Won HS, Kim KS, Moon DH, Cho KS, Park YS (April 2008). "Nonrefluxing neonatal hydronephrosis and the risk of urinary tract infection". J. Urol. 179 (4): 1524–8. doi:10.1016/j.juro.2007.11.090. PMID 18295269.
- ↑ King LR, Kazmi SO, Belman AB (October 1974). "Natural history of vesicoureteral reflux. Outcome of a trial of nonoperative therapy". Urol. Clin. North Am. 1 (3): 441–55. PMID 4610948.
- ↑ Mesrobian HG (September 2010). "Urinary proteome analysis and the management of ureteropelvic junction obstruction". Pediatr. Nephrol. 25 (9): 1595–6. doi:10.1007/s00467-010-1521-2. PMID 20407913.